Journals / Anadolu Kardiyoloji Dergisi / 2010 / Cilt: 10 - Sayı: 5

Kararsız anjina pektoris'de C-reaktif protein ve bunun koroner lezyonların koroner anjiyografik şiddeti ve yaygınlık derecesi ile ilişkisi

C-reactive protein in unstable angina pectoris and its relation to coronary angiographic severity and diffusion scores of coronary lesions

Pages
421–428
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Although, CRP was correlated with the severity and diffusion of angiographic coronary disease in patients with UAP, there was no independent association between CRP and clinical severity of UAP.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:We aimed to assess the relationship between C-reactive protein (CRP) and the severity and diffusion of coronary artery lesions in patients with unstable angina pectoris (UAP) and the independent association of CRP with this clinical situation.Methods: This cross-sectional, observational study included 50 patients.
📊
Key Findings & Data:Results: The severity score was 46±18 points in class IIB1 UAP, 36±20 points in class IIB2 and 53±18 points in class IIIB2 (p=0.017, class IIIB2 vs IIB2).
💡
Conclusion & Impact:Conclusion: Although, CRP was correlated with the severity and diffusion of angiographic coronary disease in patients with UAP, there was no independent association between CRP and clinical severity of UAP.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective:We aimed to assess the relationship between C-reactive protein (CRP) and the severity and diffusion of coronary artery lesions in patients with unstable angina pectoris (UAP) and the independent association of CRP with this clinical situation.Methods: This cross-sectional, observational study included 50 patients. Classification by Braunwald was used for UAP. The severity and diffusion of angiographic coronary disease were graded according to Reardon’s modified scoring system. Plasma CRP levels were quantified by immunoturbidimetry. Nonparametric tests were used for comparison of CRP and other risk factors, and logistic regression analysis for evaluation of independent association between CRP and unstable angina pectoris. Results: The severity score was 46±18 points in class IIB1 UAP, 36±20 points in class IIB2 and 53±18 points in class IIIB2 (p=0.017, class IIIB2 vs IIB2). Respectively, CRP levels were 6.6 mg/L, 3.8 mg/L and 4.8 mg/L (p=0.371, class IIB1 vs IIB2 vs IIIB2). Lesions with diffusion score 4 revealed higher CRP values than lesions with diffusion score 1 (11.1 mg/L vs 3.1 mg/L, p=0.048). Adjusting age, sex and smoking, assessment of partial correlation analysis showed a positive, moderately powerful and significant association between CRP levels and the severity and diffusion scores of the coronary lesions (r=0.30; p=0.034 and r=0.31; p=0.030, respectively) in the whole study group. Multiple logistic regression analysis showed no appreciable independent association between CRP and UAP (OR: 1.63, 95%CI: 0.90-5.63, p=0.093). Conclusion: Although, CRP was correlated with the severity and diffusion of angiographic coronary disease in patients with UAP, there was no independent association between CRP and clinical severity of UAP.

Özet

Amaç:C-reaktif protein (CRP) düzeyleri ile kararsız anjina pektorisli (UAP) hastalarda koroner arter lezyonlarının yaygınlığı ve şiddeti arasındaki ilişkiyi ve CRP’nin kararsız anjina kliniğine bağımsız etkisini araştırmaktı. Yöntemler: Enine-kesitli, gözlemsel bu çalışmaya yaşları 28-73 arasında 50 hasta alındı. Kararsız anjina sınıflaması Braunwald’a göre yapıldı. Hastaların anjiyografilerinde saptanan lezyonların şiddeti ve yaygınlığı Reardon’un modifiye skorlama yöntemi ile değerlendirildi. Plazma CRP düzeyleri immünotürbidimetrik yöntemle ölçüldü. Nonparametrik testler CRP ve diğer risk faktörlerinin karşılaştırılmasında, lojistik regresyon analizi CRP ve UAP arasındaki bağımsız ilişkinin araştırılmasında kullanıldı. Bulgular: Lezyonların şiddet skoru sınıf IIB1’de 46±18 puan, sınıf IIB2’de 36±20 puan ve sınıf IIIB2’de 53±18 puandı. Sınıf IIB2 ve IIIB2 arasında anlamlı fark vardı (p=0.017). Plazma CRP değerleri ise sırasıyla, 6.6 mg/L, 3.8 mg/L ve 4.8 mg/L bulundu (p=0.371). Difüzyon skoru 4 olan hastaların CRP değerleri difüzyon skoru 1 olan hastalara göre anlamlı olarak yüksek bulundu (11.1 mg/L’ye karşı 3.1mg/L, p=0.048). Tüm çalışma grubu için uygulanan bölümsel korelasyon analizinde, yaş, cinsiyet ve sigaraya göre düzeltme yapıldıktan sonra, CRP değerleri ile koroner lezyonların şiddeti ve yaygınlığı arasında direkt, orta derecede güçlü ve anlamlı bağıntı saptandı, sırasıyla (r=0.30; p=0.034 ve r=0.31; p=0.030). C-reaktif protein ve kararsız anjina pektoris arasında olabilecek bağımsız bir ilişkiyi değerlendirmek için çoklu lojistik regresyon analizi uygulandı, fakat anlamlı bir ilişki saptanmadı (OR: 1.63, %95 GA: 0.90-5.63, p=0.093). Sonuç: Kararsız anjina pektoris kliniğinden bağımsız olarak hastalarımızda CRP düzeyleri ile koroner arter lezyonlarının şiddeti ve yaygınlığı arasında ilişki bulunsa da, CRP ile kararsız anjina klinik şiddeti arasında bağımsız bir ilişki saptanmadı.

🔖

Cite This Article

KARAKUŞ, V., KÖSEOĞLU, M., BİÇEROĞLU, S., YAVAŞ, H. H., SOYSAL, D., YEŞİL, M. (2022). Kararsız anjina pektoris'de C-reaktif protein ve bunun koroner lezyonların koroner anjiyografik şiddeti ve yaygınlık derecesi ile ilişkisi. Anadolu Kardiyoloji Dergisi, Cilt: 10 - Sayı: 5, 421–428. https://ajindex.com/articles/436716

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992; 326: 242-50
  2. Malpartida F, Vivancos R, Urbano C, Mora J. Inflammation and plaque instability. Arch Cardiol Mex 2007; 77 (Supp 4): 16-22
  3. De Servi S, Mariani M, Mariani G, Mazzone A. C-Reactive protein. Increase in unstable coronary disease. Cause or effect? J Am Coll Cardiol 2005; 46: 1496-502
  4. Maseri A, Sanna T. The role of plaque fissures in unstable angina: fact or fiction? Eur Heart J 1998; (Supp K): K2-4
  5. Weissberg PL. Atherogenesis: current understanding of the causes of atheroma. Heart 2000; 83: 247-52
  6. Koenig W. Atherosclerosis involves more than just lipids: focus on inflammation. Eur Heart J 1999; 1 (Supp T): T19-T26
  7. Schnabel R, Rupprecht HJ, Lackner KJ, Lubos E, Bickel C, Meyer J, et al. for the AtheroGene Investigators. Analysis of N-terminal-probrain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease: results from the AtheroGene study. Eur Heart J 2005; 26: 241-9
  8. Hamm CW, Heeschen C, Falk E, Fox Keith AA. Acute coronary syndromes: Pathophysiology, diagnosis and risk stratification. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 1st ed. Oxford: Blackwell; 2006. p. 333-60
  9. Arroyo-Espliguero R, Avanzas P, Quiles J, Kaski JC. Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease. Atherosclerosis 2009; 204: 239-43
  10. Abdelmouttaleb I, Danchin N, Ilardo C, Aimone-Gastin I, Angioi M, Lozniewski A, et al. C-reactive protein and coronary artery disease: Additional evidence of the implication of an inflammatory process in acute coronary syndromes. Am Heart J 1999; 137: 346-51
  11. Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-4. 12. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. European Society of Hypertension-European Society of Cardiology Guidelines Committee. J Hypertens 2003; 21: 1011-53
  12. Standards of medical care for patients with diabetes mellitus. American Diabetes Association. Diabetes Care 2003; 26 (supp 1): 33-50
  13. NIH: Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults-the evidence report. National Institutes of Health. Obes Res 1998;